Axicorp

Friedrichsdorf, Germany Founded: 2002 • Age: 24 yrs Acquired By Dermapharm
OTC drugs are manufactured by Axicorp in Germany.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Axicorp

Axicorp is a company based in Friedrichsdorf (Germany) founded in 2002 was acquired by Dermapharm in June 2012. Axicorp has completed 1 acquisition, including Remedix.

  • Headquarter Friedrichsdorf, Germany
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Biocon

    & 1 more

  • Employee Count
    Not available
  • Investments & Acquisitions
  • Acquired by
    Dermapharm

    & 1 more

    (Jun 01, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Axicorp

Premium access

Detailed funding history for Axicorp

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Axicorp

Axicorp has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Biocon and Dermapharm.

All
Institutional
Investor Description Founded Year Domain Location
Dermatological and pharmaceutical medications are developed and manufactured.
Locked Locked Locked
Drug R&D services are provided for multiple therapeutic areas.
Locked Locked Locked
Premium access

Investor details for Axicorp

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Axicorp

Axicorp has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Remedix.

Investments
Premium access

Investment portfolio details for Axicorp

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Narcotic analgesics are distributed by Remedix across Europe.
Locked Locked 2016 Locked
Premium access

Complete acquisition details for Axicorp

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Axicorp

Premium access

Detailed financials for Axicorp

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Axicorp Comparisons

Axicorp Primary company
Description
OTC drugs are manufactured by Axicorp in Germany.
Location
Friedrichsdorf, Germany
Founded Year
2002
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Axicorp

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Axicorp

Premium access

Detailed competitors of Axicorp

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Axicorp

Premium access

Complete news archive for Axicorp

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Axicorp

Axicorp was founded in 2002.

Axicorp is headquartered in Friedrichsdorf, Germany. It is registered at Friedrichsdorf, Hessen, Germany.

Axicorp was established in 2002 as a manufacturer of over-the-counter drugs. Operations are centered in Friedrichsdorf, Germany, where pharmaceutical products for consumer use are produced. The company focuses on the development and distribution of non-prescription medications within the European market. Activities include formulation, packaging, and quality control processes compliant with regulatory standards in the sector. Geographic emphasis remains on domestic and regional supply chains.

Axicorp has made 1 acquisition, including Remedix.

Axicorp has 2 investors. Key investors include Biocon, and Dermapharm.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available